Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 17201-17250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06495372
Study of the Use of Methoxyflurane vs Placebo in the Management of Pain in Oral and Dental Emergencies in Adults: METODO (METhoxyflurane in ODOntology)
PHASE3Recruiting
192 participants
Started: Oct 14, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06736054
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
PHASE1Recruiting
8 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06533332
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
PHASE1Recruiting
15 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2026
6 conditions1 sponsor4 locations
NCT06888167
Food (poly)phenol Metabotypes and Beta-cell Mass and Function.
NARecruiting
40 participants
Started: Oct 14, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06515223
Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury
NARecruiting
20 participants
Started: Oct 14, 2024 · Completed: Nov 1, 2027
5 conditions2 sponsors1 location
NCT06189352
Positive Feeding of the Preterm Infant
NARecruiting
15 participants
Started: Oct 14, 2024 · Completed: May 31, 2026
6 conditions1 sponsor1 location
NCT06545916
Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder
PHASE2Recruiting
200 participants
Started: Oct 14, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors7 locations
NCT06345079
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
PHASE2Recruiting
78 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2028
1 condition2 sponsors12 locations
NCT06558799
LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
69 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor24 locations
NCT06585449
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
PHASE1Recruiting
54 participants
Started: Oct 14, 2024 · Completed: Jul 5, 2028
1 condition1 sponsor17 locations
NCT06101069
Development of MRF for Characterization of Brain Tumors After Radiotherapy
NARecruiting
60 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2026
4 conditions2 sponsors2 locations
NCT06727292
Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo
NARecruiting
66 participants
Started: Oct 14, 2024 · Completed: May 30, 2025
3 conditions3 sponsors1 location
NCT06447168
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
N/ARecruiting
424 participants
Started: Oct 14, 2024 · Completed: Jul 15, 2032
1 condition1 sponsor46 locations
NCT06324188
Early Atrial Fibrillation Ablation for Stroke Prevention in Patients with High Comorbidity Burden (EASThigh-AFNET 11)
NARecruiting
2,312 participants
Started: Oct 14, 2024 · Completed: May 31, 2030
1 condition1 sponsor5 locations
NCT06675643
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2)
N/ARecruiting
30 participants
Started: Oct 14, 2024 · Completed: Mar 15, 2026
2 conditions1 sponsor1 location
NCT07156214
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
NARecruiting
50 participants
Started: Oct 14, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor2 locations
NCT06617975
Knee Osteoarthritis and Spa Therapy
NARecruiting
80 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT06436274
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
PHASE4Recruiting
750 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2027
2 conditions7 sponsors3 locations
NCT06504394
A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65)
PHASE2Recruiting
60 participants
Started: Oct 14, 2024 · Completed: Nov 8, 2028
4 conditions1 sponsor29 locations
NCT06636682
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
PHASE2Recruiting
100 participants
Started: Oct 14, 2024 · Completed: May 4, 2027
7 conditions1 sponsor3 locations
NCT06610617
Neuromodulation of Central Sensory Integration to Improve Postural Control
NARecruiting
20 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06307340
Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations
NARecruiting
80 participants
Started: Oct 14, 2024 · Completed: Apr 30, 2026
2 conditions2 sponsors3 locations
NCT06212921
Biomarkers in Prediction of AMI
NARecruiting
250 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT06553768
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)
PHASE3Recruiting
90 participants
Started: Oct 14, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor35 locations
NCT06676553
INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)
PHASE4Recruiting
32 participants
Started: Oct 14, 2024 · Completed: Jun 30, 2028
3 conditions3 sponsors1 location
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
PHASE3Recruiting
1,800 participants
Started: Oct 14, 2024 · Completed: Dec 27, 2031
2 conditions1 sponsor470 locations
NCT07130084
Virtual Reality in Elective Caesarean Births Study (VREC)
NARecruiting
40 participants
Started: Oct 14, 2024 · Completed: Sep 1, 2025
3 conditions1 sponsor1 location
NCT06571279
Assessing the Impact of a Plant-Based Diet for Diabetes Prevention
NARecruiting
50 participants
Started: Oct 14, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06881134
Rehabilitation Combining Spatiotemporal Spinal Cord Stimulation and Real-time Triggering Exoskeleton After Spinal Cord Injury
NARecruiting
10 participants
Started: Oct 13, 2024 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT06698965
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
PHASE2Recruiting
52 participants
Started: Oct 13, 2024 · Completed: Oct 31, 2029
1 condition2 sponsors1 location
NCT06588218
Effect of Watermelon on Gut and Cardiometabolic Health
NARecruiting
36 participants
Started: Oct 13, 2024 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06295757
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NARecruiting
30 participants
Started: Oct 12, 2024 · Completed: Jan 1, 2027
3 conditions2 sponsors1 location
NCT06568614
An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Oct 12, 2024 · Completed: Dec 30, 2028
1 condition1 sponsor3 locations
NCT06625372
Comparison of Intralipid With SMOF Lipid Following HSCT
NARecruiting
50 participants
Started: Oct 12, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06608303
Macrophage Stimulating Factor in the Treatment of Diabetic Wounds
NARecruiting
40 participants
Started: Oct 12, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06639425
Efficacy of Lactobacillus Paracasei LC19 on Type 2 Diabetes
NARecruiting
60 participants
Started: Oct 12, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06950749
Effects of Robotic Gloves Along With Task-oriented Mirror Therapy on Motor Functions of Hands in Sub-acute Stroke Patients
NARecruiting
30 participants
Started: Oct 12, 2024 · Completed: Apr 30, 2025
4 conditions1 sponsor1 location
NCT06668831
Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
N/ARecruiting
30 participants
Started: Oct 12, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06646224
Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock
NARecruiting
50 participants
Started: Oct 12, 2024 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT07153809
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
NARecruiting
80 participants
Started: Oct 12, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06418659
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
EARLY_PHASE1Recruiting
37 participants
Started: Oct 12, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06670352
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN
PHASE2Recruiting
80 participants
Started: Oct 12, 2024 · Completed: Mar 15, 2026
1 condition1 sponsor2 locations
NCT06711562
Model-informed Individualized Treatment of Anti-infective Drugs
N/ARecruiting
300 participants
Started: Oct 12, 2024 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06711575
Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections
N/ARecruiting
300 participants
Started: Oct 12, 2024 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT06381388
Interaction Between the Brain Hemispheres - Key to Motor Recovery After Stroke
NARecruiting
40 participants
Started: Oct 11, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT05849662
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
PHASE1/PHASE2Recruiting
58 participants
Started: Oct 11, 2024 · Completed: Dec 31, 2029
5 conditions1 sponsor4 locations
NCT06343974
Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics
N/ARecruiting
60 participants
Started: Oct 11, 2024 · Completed: May 1, 2026
2 conditions1 sponsor2 locations
NCT06388564
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
PHASE2Recruiting
120 participants
Started: Oct 11, 2024 · Completed: Dec 1, 2029
1 condition1 sponsor70 locations
NCT06589596
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
PHASE1Recruiting
237 participants
Started: Oct 11, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor45 locations
NCT06633627
Neurological Responses in Patients with Dentine Hypersensitivity
N/ARecruiting
60 participants
Started: Oct 11, 2024 · Completed: Sep 30, 2025
1 condition3 sponsors1 location